Shanxi Zhendong Pharmaceutical (300158) — Cash Flow-to-Debt Ratio
Shanxi Zhendong Pharmaceutical (300158) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of CN¥-197.94 Million could theoretically repay 0% of its total liabilities (CN¥882.65 Million) in one year. See free cash flow generation of Shanxi Zhendong Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanxi Zhendong Pharmaceutical Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Shanxi Zhendong Pharmaceutical across 18 annual periods. Also explore 300158 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanxi Zhendong Pharmaceutical (2007–2024)
Year-by-year debt coverage analysis for Shanxi Zhendong Pharmaceutical. For market capitalisation and broader financial context, see Shanxi Zhendong Pharmaceutical (300158) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | CN¥-149.82 Million | CN¥1.32 Billion | ▲ +38.2% |
| 2023 | -0.18x | CN¥-189.95 Million | CN¥1.04 Billion | ▼ -381.9% |
| 2022 | 0.07x | CN¥86.31 Million | CN¥1.33 Billion | ▼ -53.4% |
| 2021 | 0.14x | CN¥284.45 Million | CN¥2.04 Billion | ▲ +23.8% |
| 2020 | 0.11x | CN¥221.94 Million | CN¥1.97 Billion | ▼ -10.9% |
| 2019 | 0.13x | CN¥186.35 Million | CN¥1.47 Billion | ▲ +51.4% |
| 2018 | 0.08x | CN¥154.48 Million | CN¥1.85 Billion | ▲ +280.7% |
| 2017 | 0.02x | CN¥45.09 Million | CN¥2.06 Billion | ▲ +178.6% |
| 2016 | -0.03x | CN¥-44.72 Million | CN¥1.60 Billion | ▼ -137.5% |
| 2015 | 0.07x | CN¥151.84 Million | CN¥2.04 Billion | ▼ -9.7% |
| 2014 | 0.08x | CN¥73.23 Million | CN¥888.23 Million | ▲ +192.1% |
| 2013 | -0.09x | CN¥-75.04 Million | CN¥838.64 Million | ▼ -132.3% |
| 2012 | 0.28x | CN¥189.40 Million | CN¥684.26 Million | ▲ +224.0% |
| 2011 | -0.22x | CN¥-88.73 Million | CN¥397.40 Million | ▼ -368.2% |
| 2010 | 0.08x | CN¥32.40 Million | CN¥389.13 Million | ▼ -44.1% |
| 2009 | 0.15x | CN¥42.28 Million | CN¥283.87 Million | ▲ +3.2% |
| 2008 | 0.14x | CN¥33.18 Million | CN¥229.98 Million | ▼ -67.4% |
| 2007 | 0.44x | CN¥128.65 Million | CN¥290.28 Million | — |